Baby Boomers: Should You Avoid All Weed Stocks?

Baby Boomers who wants to take advantage of the marijuana boom can invest a little in Neptune Wellness Solutions Inc. (TSX:NEPT)(NASDAQ:NEPT) or Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB). The stocks have strong upside potential.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Baby boomers, or those born between 1946 and 1964, have a history with marijuana. In the late 60s and up to the 70s, marijuana rose in popularity. Quite a number of the baby boomers were smoking pot then to get high. Today, baby boomers might seek out marijuana for medical treatment.

And who would have thought that these same users could invest in marijuana companies in the 21st century? But do marijuana stocks have a place in a baby boomer’s portfolio?

Decriminalized weed

Marijuana is no longer the “evil weed” after its legalization in Canada. The global legal marijuana market is expected to top US$66.3 billion by 2025. Both medical and recreational applications of marijuana will drive the industry’s massive growth.

Baby boomers could choose to include Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Neptune Wellness (TSX:NEPT)(NASDAQ:NEPT) in their portfolios. Both marijuana companies have strong growth potentials. The gains from these stocks could be enormous, even with token holdings.

Unique place

Neptune is in a unique position in the cannabis industry. The health and wellness company turned cannabis firm isn’t a cannabis grower but a cannabidiol (CBD) extraction service provider. CBD is the chemical compound found in the cannabis plant that doesn’t get you high. It is known for its medical benefits.

The launching of CBD derivative products in Canada might be in mid-December. Cannabis companies need Neptune’s expertise in extraction. Last June, this $510.44 million company was able to bag a three-year extraction services agreement with two cannabis producers.

Neptune will extract cannabinoids from 125,000 kilos of cannabis for Tilray. The contract with Green Organic Dutchman involves the extraction of cannabinoids from 230,000 kilos of marijuana and hemp. Neptune will also formulate and package the extracted CBDs.

The twin deals assure Neptune of operations and steady cash flow in the next three years. On top of that, its acquisition of SugarLeaf Labs last July will help create a leading extraction platform in North America. It is also in anticipation of the vast hemp-derived CBD market in the U.S.

Global supremacy

Since the growth of the cannabis industry will be on a worldwide scale, baby boomers could consider investing in Aurora. The company has a vast international presence among all the cannabis companies. It’s also the leader in terms of production capacity.

Aurora has more than a dozen of cultivation facilities that could combine to produce 700,000 kilograms a year. With export agreements in 25 countries, Aurora could garner a significant market share in both medical and recreational marijuana worldwide. It could also dominate in the high-margin derivative products.

But Aurora couldn’t rely on production capacity alone. The company needs to execute well and preserve its low-cost production. If successful, it would give Aurora a superior advantage over competitors and achieve global market dominance.

Invest with caution

As of this writing, the shares of Neptune and Aurora are selling below $8. Given the positive outlooks for both companies, the prices seem cheap. However, baby boomers should exercise restraint and take only a small position. The cannabis sector is unpredictable. Your money could go up in smoke.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »